Susquehanna Fundamental Investments’s Cyclacel Pharmaceuticals CYCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5	Closed	-$121K	–	1677
2021 Q1	$121K	Buy	+5	New	+$121K	﹤0.01%	1450